Effect of cholic acid and its keto derivatives on the analgesic action of lidocaine and associated biochemical parameters in rats

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 32, Issue 2, 2007, Pages 109-117

  Poša, Mihalj ^a   Kevrešan, Slavko ^c   Mikov, Momir ^d   Ćirin Novta, Vera ^b   Kuhajda, Ksenija ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c University of Novi Sad   (Serbia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cholic acid; Cholic acid keto derivatives; Lidocaine; Local anesthesia; Micelles; Mixed micelles

Indexed keywords

12 MONOKETOCHOLIC ACID; 3,7 DIKETOCHOLIC ACID; 3,7,12 TRIKETOCHOLIC ACID; 7 MONOKETOCHOLIC ACID; 7,12 DIKETOCHOLIC ACID; BILE ACID; BILIRUBIN; CHOLIC ACID; CHOLIC ACID DERIVATIVE; GLUTATHIONE; LIDOCAINE; LIVER ENZYME; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL MICELLE CONCENTRATION; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TRANSPORT; ENZYME ACTIVITY; HEMATOCRIT; LATENT PERIOD; LOCAL ANESTHESIA; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE;

EID: 34547601760     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190999     Document Type: Article

References (32)

1. Small D.M. (1971): Physical chemistry of cholanic acids. In: Nair P.P, Kritchevsky D. (eds). The bile acids. Chemistry, Physiology and Metabolism, Vol 1. Chemistry. New York-London, Plenum Press, 302-336.
2. Sayani A.P., Chien Y.W. (1996): Systemic delivery of peptides and proteins across absorptive mucosae. Crit. Rev. Ther. Drug. Carrier Syst., 13, 85-184.
3. Ogiso T., Iwaki M., Tanino T., Nishioka S., Higashi K., Kamo M. (1997): In vitro skin penetration and degradation of enkephalin, elcatonin and insulin. Biol. Pharm. Bull., 20, 54-60.
4. Bai J.P. (1994): Effects of bile salts on brush-border and cytosolic proteolytic activities of intestinal enterocytes. Int. J. Pharm., 111, 147-152.
5. Mikov M., Fawcett P., Kuhajda K., Kevrešan S. (2006): Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents. Eur. J. Drug Metab. Pharmacokinet., 31, 237-251.
6. Kuhajda K., Kevrešan S., Mikov M.M., Sabo A., Miljković D. (1997): 3α,7α-dihydroxy-12-keto-5β-cholanate as enhancer of insulin nasal absorption in rats. Arch. Toxicol. Kinet. Xenobiot. Metab., 5, 359-361.
7. Mikov M., Kevrešan S., Kuhajda K., Jakovljević V., Vasović V. (2004): 3α,7α-dihydoxy-12-oxo-5β-cholanate as blood-brain barrier permeator. Pol. J. Pharmacol., 56, 367-371.
8. Gordon G.S., Moses A.C., Silver R.D., Flier J.S., Carey M.C. (1985): Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. USA, 82, 7419-7423.
9. Carey M.C., Small D.M. (1972): Micelle formation by bile salts. Physical-chemical and thermodynamic considerations. Arch. Intern. Med., 130, 506-527.
10. Cannon J.B., Williams N.A., Papp K.A. (1995): Reduction of pain on intravenous infusion with bile salt formulations for a macrolide antibiotic. Int. J. Pharm., 114, 65-74.
11. Godman & Gilman's The pharmacological basis of therapeutics (2001): Hardman J.G., Limbrid L.E., Goodman Gilman A. eds, McGraw-Hill Professional, New York, 204-208.
12. Schwarz M.A., Neubert R.H., Dongowski G. (1996): Characterization of interactions between bile salts and drugs by micellar electrokinetic capillary chromatography, Part I. Pharm. Res., 13, 1174-1180.
13. Balducci R., Roda A., Pearlman R.S. (1989): A theoretical model for the critical micellar concentration of bile salts. J. Sol. Chem., 18, 355-368.
14. Greenwood J., Adu J., Davey A.J., Abott N.J., Bradbury M.W. (1991): The effect of bile salts on the permeability and ultrastructure of the perfused, energy-depleted, rat blood-brain barrier. J. Cerebr. Blood Flow Metab., 11, 644-654.
15. Coleman R., Lowe P.J., Billington D. (1980): Membrane lipid composition and susceptibility to bile salt damage. Biochim. Biophys. Acta 599, 294-300.
16. ++ accumulation in type II pneumocytes., Lung, 168, 297-308.
17. Miljković D., Kuhajda K., Hranisavljević J. (1996): Selective C-12 oxidation of cholic acid., J. Chem. Res. [S], 106-107.
18. Tullar B.F. (1951): Hemi-diethylene glycol adduct of 3,12-dihydroxy-7- ketocholanic acid and preparation thereof. US Pat. 2.549.947.
19. Kuwada S., Furushiro S., Kawashima M. (1949): Partial oxidation of methyl cholate. Annu. Rep. Takeda Res. Lab. 8, 50-61.
20. Fieser L.F., Rajagopalan S. (1950): Oxidation of Steroids. III. Selective oxidations and acylations in the bile acid series. J. Am. Chem. Soc., 72, 5530-5536.
21. Roda A., Hoffman A.F., Mysels K.J. (1983): The influence of bile salt structure on self-association in aqueous solutions. J. Biol. Chem., 258, 6362-6370.
22. Poša M., Kuhajda K., Cvejić J., Mikov M., Kevrešan S. (2004): Effect of the hydrophobic- hydrophilic balance on the critical micellar concentration of some selected bile acids, 6th Xenobiotic metabolism and toxicity workshop of Balkan countries, Banja Luka, Bosnia and Herzegovina.
23. Sârbu C., Kuhajda K., Kevresan S. (2007): Molecular modeling of bile acids and their derivatives by multivariate regression methods. 45th Meeting of the Serbian Chemical Society, Novi Sad, Serbia.
24. National Institutes of Health (1985): Guide for the care and use of laboratory animals. DHEW Publication (NIH), revised (1985): Office of Science and Health Reports, DRR/NIH, Bethesda, MD, USA.
25. Jakovljević V. (2006): Eksperimentalna farmakologija, Alfa Graf, Novi Sad, Serbia.
26. Stroev E.A., Makarova V.G. (1989): Laboratory manual of biochemistry, Mir Publishers, Moscow.
27. Tietz N.W. ed. (1997): Fundamentals of clinical chemistry. Saunders, Philadelphia, PA, USA.
28. Gion G. (1992): Labordiagnosztikai lehetoségek a gyakorló orvosok számára. Medicina, Budapest, Hungary.
29. Kapetanović I.M., Mieyal I.I. (1998): Inhibition of acetaminophene-induced hepatotoxicity by phenacetin and its alkoxy analogs. J. Pharmacol. Exp. Ther., 209, 25-30.
30. Walfson A.E. (1948): Estimation of total protein in liver homogenate. Am . J. Clin. Pathol., 18, 723-725.
31. Younes M., Siegers P.C. (1981): Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem. Biol. Interact. 34, 257-266.
32. Juszkiewicz-Donsbach J., Levy G. (1962): Effect of small variations in heat stimulus temperature on the tail flick response of rats in analgesimetry. J. Pharm. Sci., 51, 185-186.